During the past decade, UC San Diego Moores Cancer Center conducted 358 clinical trials. In the 10-year time frame, 358 clinical trials started and 187 clinical trials were completed, i.e. on average, 52.2% percent of trials that started reached the finish line to date. In the past 5 years, 137 clinical trials started and 129 clinical trials were completed. i.e. 94.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UC San Diego Moores Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 109 trials, followed by "Alliance for Clinical Trials in Oncology" with 55 trials sponsored, "University of California, San Diego" with 34 trials sponsored, "SWOG Cancer Research Network" with 26 trials sponsored and "Pfizer" with 26 trials sponsored. Other sponsors include 395 different institutions and companies that sponsored additional 207 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UC San Diego Moores Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 185 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator and "SWOG Cancer Research Network" with 10 trials as a collaborator. Other collaborators include 218 different institutions and companies that were collaborators in the rest 134 trials.

According to Clinical.Site data, the most researched conditions in "UC San Diego Moores Cancer Center" are "Breast Cancer" (29 trials), "Lymphoma" (22 trials), "Chronic Lymphocytic Leukemia" (21 trials), "Colorectal Cancer" (19 trials) and "Lung Cancer" (17 trials). Many other conditions were trialed in "UC San Diego Moores Cancer Center" in a lesser frequency.

Most popular intervention types in "UC San Diego Moores Cancer Center" are "Drug" (499 trials), "Biological" (168 trials), "Other" (154 trials), "Radiation" (97 trials) and "Procedure" (82 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (73 trials), "Quality-of-Life Assessment" (49 trials), "Placebo" (39 trials), "Nivolumab" (35 trials) and "Cisplatin" (33 trials). Other intervention names were less common.

The vast majority of trials in "UC San Diego Moores Cancer Center" are 529 trials for "All" genders, 84 trials for "Female" genders and 33 trials for "Male" genders.

Currently, there are NaN active trials in "UC San Diego Moores Cancer Center". undefined are not yet recruiting, 112 are recruiting, 155 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 256 completed trials in UC San Diego Moores Cancer Center, 7 suspended trials, and 83 terminated clinical trials to date.

Out of the total trials that were conducted in UC San Diego Moores Cancer Center, 170 "Phase 1" clinical trials were conducted, 287 "Phase 2" clinical trials and 215 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 26 trials that are defined as “Not Applicable".